Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Genitourinary 3 Plasma cell 2 Thoracic 1 Myeloid 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Osteoporosis 1 Mastocytosis, Systemic 1

Interventions

fludarabine 63 Cyclophosphamide 63 venetoclax 57 Azacitidine 52 fludarabine phosphate 50 Specimen Handling 44 Whole-Body Irradiation 40 ruxolitinib 37 Mycophenolic Acid 37 Tacrolimus 35 Melphalan 32 Busulfan 32 Biopsy 32 Cytarabine 31 Stem Cell Transplantation 27 Decitabine 27 Granulocyte Colony-Stimulating Factor 21 asciminib 19 decitabine and cedazuridine drug combination 18 Sirolimus 18 Peripheral Blood Stem Cell Transplantation 18 Injections 18 Thiotepa 17 Filgrastim 17 nilotinib 15 X-Rays 14 Methotrexate 14 Cyclosporine 14 Imatinib Mesylate 13 Magnetic Resonance Spectroscopy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Denosumab × Myeloid × 1 year × Clear all

NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡